Biologic Therapeutics Market

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
Biologic Therapeutics Market aims to provide a comprehensive presentation of the global market for Biologic Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutics. Biologic Therapeutics Market contains market size and forecasts of Biologic Therapeutics in global, including the following market information:
Global Biologic Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Biologic Therapeutics market was valued at US$ 455150 million in 2022 and is projected to reach US$ 843650 million by 2029, at a CAGR of 9.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologic Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Biologic Therapeutics Market Segment Percentages, by Type, 2022 (%)
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Global Biologic Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Biologic Therapeutics Market Segment Percentages, by Application, 2022 (%)
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Global Biologic Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Biologic Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologic Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biologic Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologic Therapeutics, market overview.
Chapter 2: Global Biologic Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Biologic Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologic Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.